Glucocorticoid-activation system mediated glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis programming alteration of adrenal dysfunction induced by prenatal caffeine exposure.
11-beta-Hydroxysteroid Dehydrogenases
/ metabolism
Adrenal Gland Diseases
/ chemically induced
Adrenal Glands
/ drug effects
Age Factors
Animals
CCAAT-Enhancer-Binding Protein-beta
/ metabolism
Caffeine
/ toxicity
Cell Line
Central Nervous System Stimulants
/ toxicity
Cholesterol Side-Chain Cleavage Enzyme
/ metabolism
Corticosterone
/ blood
Female
Fetal Growth Retardation
/ chemically induced
Hydrocortisone
/ metabolism
Insulin-Like Growth Factor I
/ metabolism
Male
Maternal Exposure
Phosphoproteins
/ metabolism
Pregnancy
Prenatal Exposure Delayed Effects
Rats, Wistar
Adrenal developmental toxicity
Glucocorticoid-activation system
Glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis programming
IGF1 signal pathway
Prenatal caffeine exposure
Journal
Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
27
08
2018
revised:
26
11
2018
accepted:
04
12
2018
pubmed:
12
12
2018
medline:
27
2
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
Glucocorticoids play a major factor in fetal maturation and fate decision after birth. We have previously demonstrated that prenatal caffeine exposure (PCE) resulted in adrenal dysplasia. However, its molecular mechanism has not been clarified. In the present study, a rat model of intrauterine growth retardation (IUGR) was established by PCE, and offspring were sacrificed. Moreover, NCI-H295 A cells were used to confirm glucocorticoid-related molecular mechanism. Results showed that PCE fetal weight decreased, and the IUGR rate increased, while serum corticosterone levels increased but insulin-like growth factor 1 (IGF1) levels decreased. Fetal adrenals exhibited an activated glucocorticoid-activation system, and the downregulated expression of IGF1 signal pathway and steroidal synthetases. For adult rats, there was no significant change in the glucocorticoid-activation system in the PCE group, the IGF1 signal pathway showed increased trend, and the expression levels of adrenal steroidal synthetases were close to normal. The data in vitro showed that the cortisol of 1200 nM can inhibit the expression of adrenocortical cell steroidal synthetases and IGF1 signal pathway when compared with the control. Meanwhile, the glucocorticoid-activation system was activated while GR inhibitor mifepristone can reverse the effect of cortisol. Furthermore, cortisol can also promote GR into the nucleus after its activation. Based on these findings, we speculated that high concentrations of glucocorticoid in utero led to GR in the nucleus through its activation and then inhibited the IGF1 signaling pathway by activating the glucocorticoid-activation system, which could further downregulate steroid synthesis.
Identifiants
pubmed: 30528684
pii: S0378-4274(18)31803-4
doi: 10.1016/j.toxlet.2018.12.001
pii:
doi:
Substances chimiques
CCAAT-Enhancer-Binding Protein-beta
0
Central Nervous System Stimulants
0
IGF1 protein, human
0
Phosphoproteins
0
insulin-like growth factor-1, rat
0
steroidogenic acute regulatory protein
0
Caffeine
3G6A5W338E
Insulin-Like Growth Factor I
67763-96-6
11-beta-Hydroxysteroid Dehydrogenases
EC 1.1.1.146
Cholesterol Side-Chain Cleavage Enzyme
EC 1.14.15.6
Corticosterone
W980KJ009P
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-17Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.